2018 AANS Annual Scientific Meeting-The Relevance of Metastatic Spinal Tumors to a Neurosurgeon: Disease Prevalence and Survival in a New Era of Oncological Treatments

The Relevance of Metastatic Spinal Tumors to a Neurosurgeon: Disease Prevalence and Survival in a New Era of Oncological Treatments

Back to course

Video Transcription

Video Summary

In this video, the topic discussed is advancements in the management of spinal oncology. Dr. Gokaslan begins by highlighting the relevance of metastatic spinal tumors to neurosurgeons in the context of precision medicine and cancer treatment. He presents data showing that spinal metastasis is a common problem, with up to 70% of cancer patients experiencing metastatic involvement in their spinal column. Dr. Gokaslan emphasizes that the problem is only expected to increase as the population ages and the number of cancer survivors grows. He explains the various treatment options available, including surgery, radiation, and minimally invasive procedures, and discusses the importance of assessing factors such as neurological status, primary tumor type, and spinal instability when determining treatment plans. He also highlights the significance of genotyping and molecular profiling of tumors in decision-making and discusses how targeted therapies have improved patient outcomes. In conclusion, Dr. Gokaslan emphasizes the importance of keeping up with recent advances in cancer care for neurosurgeons managing spinal metastases.

Asset Caption

Ziya L. Gokaslan, MD, FAANS

Keywords

spinal oncology

metastatic spinal tumors

precision medicine

treatment options

neurosurgeons